1. Serum bile acids in seven patients with adult type myotonic dystrophy and 22 normal persons were quantitatively analysed by gas-liquid chromatography and gas chromatography-mass spectrometry for cholesterol, y-glutamyltransferase and bilirubin. There was no bile obstruction in any patient.
Introduction
Myotonic muscular dystrophy (MMD), causing general disturbances in addition to muscle dysfunction, is apparently characterized by a metabolic morbidity resulting in generalized abnormalities. The relations between MMD and cholesterol metabolism have been demonstrated in human and animal experiments with administration of an inhibitor of cholesterol synthesis [ 1 I. Cholesterol metabolism is regulated quantitatively by bile acids. In patients with MDD gallstones are a common occurrence [2l. This suggests that a disturbance in bile acid metabolism may underlie the pathogenesis of MMD. These observations led us to analyse and identify the serum and biliary bile acids in patients with MMD.
This paper describes the unusual composition of bile acids in serum and bile from patients with MMD, and proposes some explanation of the abnormalities of bile acids in these patients. or in the hospital. All individuals had normal diets and none was receiving medication.
The patients in the hospital were asked to fast for 12 h. Blood samples from both out-and in-patients were collected with the patients, consent and after clotting serum was separated by centrifugation. Portions of the serum were routinely examined for free and esterified cholesterol, y-GT and total and direct bilirubin. For the quantitative analysis of bile acids, 3.5 ml of serum was used.
Control sera were obtained from seven males and 15 females, age range 21-68 years, with normal liver function, which was checked by assay of cholesterol, y-GT, bilirubin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, urea nitrogen, total protein and electrolytes.
The subjects were divided into three groups: 1, a group of five females with adult MMD, mean age 41 years, having an affected child (children) with early onset MMD; 2, a group of two males with adult MMD, mean age 36 years; 3, 22 normal subjects whose sera were mixed and divided into five aliquots.
Bile was also collected by duodenal intubation Solvoly sis
Alkaline hydrolysis
Addition of P-muricholic acid (internal standard) -Extraction with n-hexane after injection of cholecystokinin from two women, ages 35 and 29 years, of the first group, from a 13-year-old man of the second group, and from a healthy 27-year-old women of the third group. For the analysis of bile acids, 0.1 ml of bile was used.
Extraction of bile acids from serum and their separation into sulphated and non-sulphated fractions (Scheme I )
Bile acids in serum (3-5 ml) were extracted with a column of Amberlite XAD-2 by the method of Ikawa et al. [31. The extract was fractionated into sulphate-conjugated and nonsulphate-conjugated fractions through a column of Sephadex LH-20 (4g) by the method of Makino et al. 141 .
After the sulphated fraction was solubilized by the method of Alme et al.
[5], both the sulphated and non-sulphated fractions were hydrolysed in KOH solution (2 mol/l) at 13OOC for 4 h, and then @-MCA (4pg) was added as an internal standard.
The free bile acids liberated from the sulphated fraction were extracted with 4 x 20 ml of ether Purification by aluminium oxide t 1 F-Acetylati;,::na;$;lanhydride b Table 2 Fig. I(a) Fig. l(b 1 SCHEME 2. Identification of serum bile acids after group separation by silicic acid column chromatography E/C, Ethanol/chloroform (parts v/v shown in parentheses). GC-MS, Gas chromatography-mass spectrometry.
after acidification to pH 1 with HCI (6 mol/l). The free bile acids obtained from the nonsulphated fraction were extracted with 4 x 20 ml of ether under the same acidic conditions, after removal of unsaponifiable matter by extraction of the alkaline hydrolysate with 2 x 5 ml of hexane.
The hexane extract was separated by centrifugation and extracted with ether in the same way.
The pooled extracts were washed with portions (5 ml) of water to neutrality and dehydrated over anhydrous sodium sulphate (10 g). The ether extract was filtered off and evaporated to dryness.
Purgcation of bile acids in the non-sulphated fraction by column chromatography on aluminium oxide
For further purification, free bile acids obtained from the non-sulphated fraction were methylated with diazomethane in the usual way. They were transferred quantitatively to an aluminium oxide column (2 g) with about 10 ml of benzene/hexane (1 : 9, v/v) and the column was washed with approximately 40 ml of the same solvent mixture. All bile acid methyl esters were then eluted with 60 ml of methanol/acetone (1 : 9, v/v).
Group separation of bile acids by column chromatography on silicic acid (Scheme 2 )
Bile acids were chromatographed on a column of silicic acid 
Analysis by gas-liquid chromatography
Samples of methylated bile acids were acetylated in acetic anhydride at 140°C for 4 h. Acetyl derivatives of bile acid methyl esters were dissolved in acetone and analysed by g.1.c. under the conditions described by Ayaki 171.
Mass spectrometry
Mass spectra of bile acids were obtained on a Hitachi M-80 gas chromatograph-mass spectrometer (Hitachi Co., Tokyo, Japan 
Detection of iso-UDCA and iso-CDCA in serum
Bile acids in serum (20 ml from two females with adult type MMD, and serum from normal persons) were extracted with Amberlite XAD-2 and treated by alkaline hydrolysis after solvolysis. Free bile acids were extracted with ether, and chromatographed on a column of silicic acid. the same R, as UDCA, 3/3,7a-dihydroxy-5/3-cholan-24-oic acid and 3/3,7pdihydroxy-5/3-cholan-24-oic acid, were scraped together and purified by column chromatography on silicic acid (5 g). The material eluted with 50 ml of ethanol/chloroform (4 : 96, v/v) was converted into the trimethylsilyl ester derivative, which was then analysed by gas chromatography-mass spectrometry on a glass-coil column (1 m x 3 m m i.d.) packed with 3% HI-EFF-8BP on 80/100 mesh Gaschrom-Q at a column temperature of 218OC (81.
Extraction of bile acids from bile and their analysis by g.1.c. (Scheme 3)
Bile acids in bile collected after gall-bladder contraction (B-bile, 0.1 ml) were extracted with Amberlite XAD-2 and treated by alkaline hydrolysis after solvolysis. Free bile acids were extracted with ether, and converted into methyl ester acetyl derivatives, which were then analysed by the procedure used for serum bile acid analysis.
Results

Serum cholesterol, y-GT and bilirubin
The results of the routine clinical tests are shown in Table 1 . There were no significant sex differences in the values of these tests among the patients. The mean value of serum total cholesterol level in the patients was significantly lower than that in the normal controls. The mean value of serum y-GT activity in the patients was significantly higher than that in the normal controls. These results are in agreement with other reports concerning patients with MMD 191. No significant difference in the serum bilirubin level was noted. This might deny the existence of bile obstruction in these patients, which, as a consequence, indicates that the behaviour of their serum bile acids did not appear to be a secondary change due to bile obstruction.
Ident$cation and quantitative determination of serum bile acids
The total patterns of methyl ester acetyl derivatives from g.1.c. on OV-1 of the extract by hexane, and of the non-sulphated and sulphated fractions from the patients' serum bile acids, are shown in Fig. 1 . FIG. 1. Gas-liquid chromatographs on OV-1 of methyl ester acetyl derivatives of (a) the extract with hexane, (b) the non-sulphated fraction and (c) the sulphated fraction, from the patients' serum bile acids. P, Peak.
The materials with the same retention time as peak (a-1) and (b-1) in Fig. l(a) and l(b) were eluted in fraction (I) by silicic acid column chromatography and showed the same mass spectra as shown in Fig. 2(a) . It showed two prominent peaks (mle 368 and 247), which agreed with two mass units lower than those (mle 370 and 249) found in the electron impact-MS spectrum of 3/3-hydroxy-5-cholen-24-oic acid. On the other hand, acetylated cholesterol showed the same spectrum (Fig. 2 ). This material thus seems to be cholesterol rather than the derivative of 3~hydroxy-5-cholen-24-oic acid having a double bond in the side chain. The latter possibility has still to be examined. Identification and quantitative determination of individual bile acids in a serum sample were b-2, b-3, b-4, b-5, b-6, b-7, c-1, c-2 or c-3 in Fig. 1. tr., Trace amount (<0.01 pg/ml). N.S., Not significant; N.D., not detectable.
Serum bile acids (pnol/l)
Peak no. (Fig. I) . carried out by g.1.c. without any preliminary group separation by silicic acid column chromatography. The results are listed in Table 2 . Significant differences between the control and patients are shown in the materials corresponding to the peaks described below. Peak (b-2) (Fig. Ib) and peak (c-2) (Fig. Ic) . The materials of the peak (b-2) and the peak (c-2) w i t h a retention time corresponding to that of DCA on gas chromatography was eluted in fraction I1 by silicic acid column chromatography and was identified as DCA by gas chromatography-mass spectrometry in both the controls and patients (Figs. 3 and 4) .
The serum level of sulphated and nonsulphated conjugates of DCA in patients with adult type MMD was three times that in normal controls.
Peak (b-4) (Fig. Ib) . By silicic acid column chromatography the material with the same retention time as cholic acid on g.1.c. was separated into two components. The major component was eluted in fraction IV and was identified as cholic acid by gas chromatography-mass spectrometry. The minor one eluted in fraction I1 could not be identified, but gas chromatographic-mass spectometric analysis implied the presence of a similar steroid-nucleus structure to CDCA with a longer side chain [peak (2-3) in Fig. 3(b) and Fig. 5(c) 1. Contamination by the unknown component in the peak (b-4) amounted to 22.6% in patients but only a trace in the controls.
Peak (b-5) (Fig. Ib) . The material of peak (b-5) with a retention time corresponding to that of UDCA on gas chromatography was eluted in fraction I1 only by silicic acid column chromatography and was revealed as a mixture by data from the mass chromatogram [peak (b-5) in Fig.  61 . The control values of crude UDCA calculated as described below corresponded to those in the earlier work with the same analytical procedure
1101.
There are significant correlations between the amounts of peak (b-5) and peak (b-3), peak (b-7) and y-GT respectively in the seven patients as shown below.
Y: the amount of peak (b-5) was tentatively calculated as the bile acid having the same detector response as UDCA (pmolll). Y : the same Y as described above. X: the amount of peak (b-7) was tentatively calculated as the bile acid having the same detector response as P-MCA (pmol/l).
Regression line: y = 0.13 + 0.38x(P < 0.05) (n = 7). Correlation coefficient: r = 0.75 (P < 0.05) (n = 7).
Y: the same Y as described above. X: the amount of y G T (i.u./l).
Correlation coefficient: r = 0.70 (P < 0-1) (n = 7). (Fig. Ib) . Peak b-7 in Fig. 1 (b) was analysed by gas chromatography-mass spectrometry and the following fragmentation pattern was obtained (Fig. 7) ; when the mass spectrum was recorded as its methyl acetate ester, nothing assumed to be the molecular ion (M) was found and two series of fragment ions were recorded, one at mle 504,472 and 412 and the other at mle 504, 454 and 394. These could have possibly arisen from dihydroxymono-oxocholanic acid (Fig. 7a) .
Peak (b-7)
5
-0 600 100. 3 (a) ; (c) peak (2-1) in Fig. 3 (b) , i.e. peak (b-2) in Fig. 1 (b) . because it showed a prolonged retention time on gas chromatography with a column packed with 3% ov-1.
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Detection of iso-UDCA and iso-CDCA in patients' sera By t.1.c. on chloroform/acetone/methanol (1 10: 35: 3, by vol.) UDCA, 3p,7/3-dihydroxy-SP-cholan-24-oic acid and 3p,7a-dihydroxy-SP-cholan-24-oic acid could not be separated but the combined spot could partially be separated from DCA and totally separated from CDCA.
The scraped zone corresponding to standard UDCA, from t.1.c. of fractions I and 11 (ethanol/ chloroform, 2-4 : 98-96, v/v) obtained by silicic acid chromatography of serum bile acids from the patients and the controls, was analysed by gas chromatography-mass spectrometry as described below (Figs. 8 and 9) . The patients' Fig. 3(a) . The retention time of peak (b-5) in Fig. 6 corresponds to that of peak (b-5) in Fig. 1 (b) . P, Peak. Fig. 3(b) , i.e. peak (b-7) in Fig. 1 (b) .
FIG. 6. Mass chromatogram of
Bile acid abnormality in myotonic dystrophy
specimens consisted of four components, from peak (I) to peak (V). Peak (I), having the same retention time relative to deoxycholic acid (RRT) (0-83) as 3/3,7a-diiydroxy-5/%cholan-24-oic acid, showed the base peak at mle 370 (M-2 x 90) and peaks at mle 460 (M-90) and mle 255 (ABCD ring). The peaks at mle 243, 249 and 262 are characteristic of a 3,7-bis-(trimethylsiloxy) structure in a dhydroxy bile acid. As a result, peak (I) was taken to be 3/3,7a-dihydroxy-5/%cholan-24-oic acid. Peak (11) was identified as DCA by gas chromatography-mass spectrometry and RRT (1.00) on g.1.c. Peak (IV) was 3/3,7/%dihydroxy-5/%cholan-24-oic acid and peak (V) was UDCA. In the control specimen, the material Corresponding to 3/3,7a-dihydroxy-5/3-cholan-24-oic acid was nonexistent and even the fragment ion (mle 370) was not detected at the RRT corresponding to 3/3,7a-dihydroxy-5~cholan-24-oic acid.
Identifiation and quantitative determination of biliary bile acids
The analysis of binary bile acids was performed by the procedure used for serum analysis, without separation of bile acids into sulphateconjugated and non-sulphate-conjugated fractions. The total patterns on g.1.c. are shown in Fig. 10 . The results of the quantitative analysis are listed in Table 3 . The content of ursodeoxycholic acid in bile from one normal person determined by our analytical procedures corresponded to the average value for Japanese and (b) and (c), of methyl trimethylsilyl ester derivatives of the scraped zone, corresponding to the same R , as UDCA, from t.1.c. of the fractions I and 11 [ethanol/chloroform (2-4: 98-96, v/v) subjects reported by Igimi 1 1 11. In three patients the content of ursodeoxycholic acid was remarkably decreased.
Discussion
It has been suggested that MMD may be the expression of a cholesterol metabolic defect, perhaps analogous to experimental inhibition of cholesterol synthesis 1 11.
On analysis of serum from seven patients with adult type MMD, one of the unusual bile acids, corresponding to peak (b-7) in Fig. l(b) , correlated quantitatively with the material corresponding to the peak (b-5) (correlation coefficient 0.75, P < 0.05). This might indicate an abnormality of bile acid metabolism in patients with MMD, with relative impairment in the degradation of the cholesterol side chain resulting in accumulation of dihydroxymonooxocholanic acid with a longer side chain (peak 2-7 in Fig. 36) , and dihydroxycholanic acid having a similar steroid-nucleus structure to chenodeoxycholic acid with a longer side chain (peak 2-3 in Fig. 36 ).
In the peak (b-5) in the patients' sera, 3P,7a-dihydroxy-5P-cholan-24-oic acid was detected, besides 3p,7/3-dihydroxy-5b-cholan-24-oic acid and UDCA. Ordinarily 3/3,7a-dihydroxy-5~-cholan-24-oic acid has been found only in human urine and faeces, and not in serum 1121.
Although the total amount of serum bile acids is within the normal limit, an unusual composition of bile acid constituents is apparent in the serum of patients, i.e. increased DCA and decreased crude cholic acid and UDCA fractions on g.1.c. Such an irregularity in the pattern of serum bile acid composition has not been reported.
In this study a distinct difference was revealed between the patients and the controls in respect of serum level of DCA. The patients' serum DCA was approximately three times that of the control, although the patients' serum LCA, unlike DCA, was near the level of that of the controls. This cannot be accounted for by 7a-dehydroxylation of intestinal flora as a result of constipation 1131. Back 114, 151 has demonstrated the primary biosynthesis of DCA in human liver through an alternative pathway of cholesterol catabolism under pathological conditions. His findings imply the existence of such an alternative pathway in MMD.
With regard to the influence of the increased level of serum DCA, it is known that the effect of sodium DCA on the degradation of arachidonyllabelled phosphatidylinositols by brain synaptosomes shows optimal activity 1161. This may suggest a reason why a child with mental retardation might be born from the mother with MMD.
As compared with the control, the crude UDCA concentration in every patient's serum and bile was significantly lower. As to the biological action of UDCA, Kimura I171 has shown that the cytotoxicity of CDCA was decreased after preincubation with UDCA or by addition of UDCA and CDCA in the media. Greim et af. 181 have explained that the increase of UDCA biosynthesis in cholestasis could be considered a protective mechanism to prevent accumulation of strongly detergent bile acid likely to injure cell membranes. In contrast to such an effect of UDCA, DCA is cytotoxic to human cells [191. This study revealed that the ratio of DCA to crude UDCA in patients' serum was ten times that in control serum. These mutually reinforced actions of DCA and UDCA against human cells in MMD may account for the involvement of tissues other than skeletal muscle.
After UDCA is administered intravenously, electron microscopy shows that the Golgi apparatus within the pancreatic islet cells is enlarged and the exocrine secretion is remarkably stimulated 1201. This could be interpreted as indicating that UDCA affects the functions of the Golgi apparatus, which are the synthesis of membrane glycoprotein, the recycling of plasma On the other hand, some aspects of the disease may be caused by the epimers of bile acids, i.e. 3~,7a-dihydroxy-5~cholan-24-oic acid, which is normally eliminated in the urine and is not detectable in serum. Because an epimer of a structurally asymmetrical compound such as a bile acid will act with selective specificity in metabolism, the existence of various epimers of bile acids in patients, whether due to retention or to increased synthesis, might disturb bile acid metabolism in general.
It has been shown that bile acids increase the cellular membrane fluidity [231. The abnormalities of bile acids in patients may be related to the increased fluidity of their erythrocyte membranes, which has been suggested as a cause of the clinical sign of myotonia in muscle 1241. As to the mechanism of muscular contraction, Shimizu & Yano 1251 showed the importance of the environmental fluidity around the interaction between actin and myosin, whereby molecular reactions are transformed into an orientated tissue response, i.e. a chemical process changing to a mechanical process. Thus the detergent abnormalities of bile acids may account in some degree for the abnormalities in patients' muscular contraction.
